Linda Vatan
- Immunology top 1%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Weiping ZouIlona KryczekLili ZhaoShuang WeiWojciech SzeligaEnde ZhaoNisha NagarshethDongjun Peng
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)Immune cells in cancer (11 papers)Immune Cell Function and Interaction (11 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesChinaPoland
In The Last Decade
Linda Vatan
23 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 2.4k
- Oncology 2.3k
- Molecular Biology 1.7k
- Cancer Research 818
- Pulmonary and Respiratory Medicine 418
Countries citing papers authored by Linda Vatan
This map shows the geographic impact of Linda Vatan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Vatan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Vatan more than expected).
Fields of papers citing papers by Linda Vatan
This network shows the impact of papers produced by Linda Vatan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Vatan. The network helps show where Linda Vatan may publish in the future.
Co-authorship network of co-authors of Linda Vatan
This figure shows the co-authorship network connecting the top 25 collaborators of Linda Vatan. A scholar is included among the top collaborators of Linda Vatan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Vatan. Linda Vatan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 40 | |
| 3 | 16 | |
| 4 | 90 | |
| 5 | 131 | |
| 6 | 69 | |
| 7 | 91 | |
| 8 | 326 | |
| 9 | Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regressionbreakdown → | 449 |
| 10 | Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumorbreakdown → | 579 |
| 11 | 19 | |
| 12 | 30 | |
| 13 | 14 | |
| 14 | 213 | |
| 15 | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapybreakdown → | 893 |
| 16 | 297 | |
| 17 | Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cellsbreakdown → | 540 |
| 18 | 1 | |
| 19 | 122 | |
| 20 | 1 |
About Linda Vatan
Linda Vatan is a scholar working on Immunology, Oncology and Genetics, having authored 25 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (11 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.3k citations) and Cancer Research (818 citations). Linda Vatan has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Weiping Zou, Ilona Kryczek, Lili Zhao, Shuang Wei, Wojciech Szeliga, Ende Zhao, Nisha Nagarsheth, Dongjun Peng, Yali Dou and Rebecca Liu. Their work appears in journals such as Nature, Science and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.